tiprankstipranks
Trending News
More News >
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market

Akero Therapeutics (AKRO) Technical Analysis

Compare
593 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Akero Therapeutics Inc’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is 2.93, suggesting Akero Therapeutics Inc is a Buy.
Akero Therapeutics Inc’s (AKRO) 20-Day exponential moving average is 51.87, while Akero Therapeutics Inc’s (AKRO) share price is $54.2, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 50-Day exponential moving average is 47.63, while Akero Therapeutics Inc’s (AKRO) share price is $54.2, making it a Buy.

Akero Therapeutics (AKRO) Pivot Points

Jun 22, 2025, 07:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
52.17
52.89
53.89
54.61
55.62
56.34
57.34
Fibonacci
52.89
53.55
53.95
54.61
55.27
55.68
56.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Jun 22, 2025, 07:38 AM
Period
Simple
Exponential
MA5
55.17Sell
54.69Sell
MA10
54.59Sell
54.04Buy
MA20
51.97Buy
51.87Buy
MA50
45.22Buy
47.63Buy
MA100
45.99Buy
44.02Buy
MA200
37.56Buy
37.91Buy
Akero Therapeutics Inc’s (AKRO) 10-Day exponential moving average is 54.04, while Akero Therapeutics Inc’s (AKRO) share price is $54.2, making it a Buy.
Akero Therapeutics Inc’s (AKRO) 100-Day exponential moving average is 44.02, while Akero Therapeutics Inc’s (AKRO) share price is $54.2, making it a Buy.
Akero Therapeutics Inc’s (AKRO) stock price is $54.2 and Akero Therapeutics Inc’s (AKRO) 50-day simple moving average is 45.22, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $54.2 and Akero Therapeutics Inc’s (AKRO) 100-day simple moving average is 45.99, creating a Buy signal.
Akero Therapeutics Inc’s (AKRO) stock price is $54.2 and Akero Therapeutics Inc’s (AKRO) 200-day simple moving average is 37.56, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Jun 22, 2025, 07:38 AM
Name
Value
Implied Action
RSI (14)
62.96
Neutral
STOCH (9,6)
60.41
Neutral
STOCHRSI (14)
76.75
Neutral
MACD (12,26)
2.93
Buy
ADX (14)
30.28
Neutral
Williams %R
-34.07
Buy
CCI (14)
60.02
Neutral
ATR (14)
2.65
-
Ultimate Oscillator
64.50
Neutral
ROC
9.16
Buy
Akero Therapeutics Inc’s (AKRO) Relative Strength Index (RSI) is 62.96, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Trend Strength Indicator (ADX) is 30.28, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Commodity Channel Index (CCI) is 60.02, creating a Neutral signal.
Akero Therapeutics Inc’s (AKRO) Price Rate of Change (ROC) is 9.16, creating a Buy signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Buy.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 62.96, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is 2.93, which suggests AKRO is a Buy.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 55.17, which suggests AKRO is a Sell.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 51.97, which suggests AKRO is a Buy.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 45.22, which suggests AKRO is a Buy.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 37.56, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -34.07, which suggests AKRO is a Buy.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is 60.02, which suggests AKRO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis